日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical safety assessment and immunological evaluation of xenogeneic mammary cells of porcine origin, utilized as an intralesional immunotherapeutic agent.

对用作病灶内免疫治疗剂的猪源异种乳腺细胞进行临床前安全性评估和免疫学评价。

Liu Liang-Chih, Shyr Chih-Rong, Lin Ting-Yu, Wu Ching-Feng, Shih Chen-Kai, Ma Wen-Lung, Yang Chi-Yu, Huang Chi-Ping

Evaluating Therapeutic Efficacy of Intravesical Xenogeneic Urothelial Cell Treatment Alone and in Combination with Chemotherapy or Immune Checkpoint Inhibition in a Mouse Non-Muscle-Invasive Bladder Cancer Model.

在小鼠非肌层浸润性膀胱癌模型中,评估膀胱内异种尿路上皮细胞治疗单独及与化疗或免疫检查点抑制剂联合治疗的疗效

Shyr Chih-Rong, Wu Ching-Feng, Yang Kai-Cheng, Ma Wen-Lung, Huang Chi-Ping

Immunotherapeutic Agents for Intratumoral Immunotherapy

用于肿瘤内免疫治疗的免疫治疗药物

Shyr, Chih-Rong; Liu, Lang-Chi; Chien, Hui-Shan; Huang, Chi-Ping

Utilizing Xenogeneic Cells As a Therapeutic Agent for Treating Diseases

利用异种细胞作为治疗疾病的疗法

Huang, Chi-Ping; Yang, Chi-Yu; Shyr, Chih-Rong

Xenogeneic cell therapy provides a novel potential therapeutic option for cancers by restoring tissue function, repairing cancer wound and reviving anti-tumor immune responses

异种细胞疗法通过恢复组织功能、修复癌变创伤和激活抗肿瘤免疫反应,为癌症治疗提供了一种新的潜在治疗选择。

Huang, Chi-Ping; Chen, Chi-Cheng; Shyr, Chih-Rong

Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression

使用羟氟他胺或雄激素受体降解增强剂ASC-J9进行抗雄激素治疗可增强卡介苗疗效,从而更好地抑制膀胱癌进展

Shang, Zhiqun; Li, Yanjun; Zhang, Minghao; Tian, Jing; Han, Ruifa; Shyr, Chih-Rong; Messing, Edward; Yeh, Shuyuan; Niu, Yuanjie; Chang, Chawnshang

MicroRNA-21 promotes the ovarian teratocarcinoma PA1 cell line by sustaining cancer stem/progenitor populations in vitro

MicroRNA-21通过在体外维持癌症干细胞/祖细胞群来促进卵巢畸胎瘤PA1细胞系的增殖。

Chung, Wei-Min; Chang, Wei-Chun; Chen, Lumin; Chang, Ying-Yi; Shyr, Chih-Rong; Hung, Yao-Ching; Ma, Wen-Lung

Decreased tumorigenesis and mortality from bladder cancer in mice lacking urothelial androgen receptor

缺乏尿路上皮雄激素受体的小鼠膀胱癌肿瘤发生率和死亡率降低

Hsu, Jong-Wei; Hsu, Iawen; Xu, Defeng; Miyamoto, Hiroshi; Liang, Liang; Wu, Xue-Ru; Shyr, Chih-Rong; Chang, Chawnshang

Reduced osteoblast activity in the mice lacking TR4 nuclear receptor leads to osteoporosis

缺乏TR4核受体的小鼠成骨细胞活性降低会导致骨质疏松症。

Lin, Shin-Jen; Ho, Hsin-Chiu; Lee, Yi-Fen; Liu, Ning-Chun; Liu, Su; Li, Gonghui; Shyr, Chih-Rong; Chang, Chawnshang

Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor α knockout mice

雌激素受体α敲除小鼠的基质成纤维细胞前列腺分支形态发生减少,但上皮细胞前列腺分支形态发生未见减少。

Chen, Ming; Yeh, Chiuan-Ren; Shyr, Chih-Rong; Lin, Hsiu-Hsia; Da, Jun; Yeh, Shuyuan